Skip to main content

Table 5 Decellularization protocol for replacement heart valves in eligible full-text articles

From: Clinical performance of decellularized heart valves versus standard tissue conduits: a systematic review and meta-analysis

Authors

Decellularization components and conditions

Detergent(s)

Enzyme(s)

Antimicrobial agent(s)

Temperature

Bechtel et al. 2005a [39]

Hypotonic sterile water solution (treatment); multi-day washout period with isotonic neutral buffer solution (unspecified)

Ribonuclease + deoxyribonuclease

Antibiotic + antimycotic (unspecified)

 

Bechtel et al. 2008a [40]

Hypotonic sterile water solution (treatment); multi-day washout period with isotonic neutral buffer solution (unspecified)

Ribonuclease + deoxyribonuclease

Antibiotic + antimycotic (unspecified)

 

Bibevski et al. 2017a [41]

Hypotonic sterile water solution (treatment); multi-day washout period with isotonic neutral buffer solution (unspecified)

Ribonuclease + deoxyribonuclease

Antibiotic + antimycotic (unspecified)

 

Boethig et al., 2019b [42]

0.5% sodium deoxycholate (Sigma Chemical Company, St Louis, Missouri, USA) + 0.5% sodium dodecylsulfate (Carl Roth GmbH, Karlsruhe, Germany); 0.9% NaCl (washing)

 

Penicillin-streptomycin (100 IU/mL)e

20 °C (treatment); 4 °C (storage)

Brown et al. 2010a [43]

Hypotonic sterile water solution (treatment); multi-day washout period with isotonic neutral buffer solution (unspecified)

Ribonuclease + deoxyribonuclease

Antibiotic + antimycotic (unspecified)

 

Brown et al. 2011a [44]

Hypotonic sterile water solution (treatment); multi-day washout period with isotonic neutral buffer solution (unspecified)

Ribonuclease + deoxyribonuclease

Antibiotic + antimycotic (unspecified)

 

Burch et al. 2010a [45]

Hypotonic sterile water solution (treatment); multi-day washout period with isotonic neutral buffer solution (unspecified)

Ribonuclease + deoxyribonuclease

Antibiotic + antimycotic (unspecified)

 

Cebotari et al. 2011 [46]

0.5% sodium deoxycholate + 0.5% sodium dodecylsulfate (treatment); 0.9% NaCl (washing)

 

Penicillin-streptomycin (100 IU/mL)e

20 °C (treatment); 4 °C (storage)

da Costa et al. 2005c [47]

1 to 2% sodium deoxycholic acid (treatment); PBS in decreasing concentrations (rinsing); 70% ethanol; pulsating PBS (repeating rinsing)

  

37 °C (storage for 24 h); 20 °C (treatment)

da Costa et al. 2007 [33]

10% dimethyl sulphoxide + 10% fetal bovine serum; 0.9% NaCl (thawing) + 10% fetal bovine serum (gradual dilution); continuous shaking over 24 h with either 1% sodium deoxycholic acid + 80% ethanol OR 0.1% sodium dodecylsulfate; nutrient solution (harvesting)

 

Cefoxitin (240 μg/mL) + lincomycin (120 μg/mL) + vancomycin (50 μg/mL) + polymyxin B (100 μg/mL)

4 °C (treatment); Storage within −150 °C liquid nitrogen vapour; 42 to 50 °C (thawing)

da Costa et al. 2018d [48]

0.1% sodium dodecylsulfate (treatment); PBS (storage)

  

37 °C (shaking); 4 °C (storage up to 90 days)

Etnel et al. 2018d [49]

0.1% sodium dodecylsulfate (treatment); PBS (storage)

  

37 °C (shaking); 4 °C (storage up to 90 days)

Konuma et al. 2009a [50]

Hypotonic sterile water solution (treatment); multi-day washout period with isotonic neutral buffer solution (unspecified)

Ribonuclease + deoxyribonuclease

Antibiotic + antimycotic (unspecified)

 

Ruzmetov et al. 2012a [51]

Hypotonic sterile water solution (treatment); multi-day washout period with isotonic neutral buffer solution (unspecified)

Ribonuclease + deoxyribonuclease

Antibiotic + antimycotic (unspecified)

 

Sarikouch et al. 2016 [34]

0.5% sodium deoxycholate (Sigma Chemical Company, St Louis, Missouri, USA) + 0.5% sodium dodecylsulfate (Carl Roth GmbH, Karlsruhe, Germany) (treatment); PBS (6 cycles of washing, 12 h each)

 

Penicillin-streptomycin (100 IU/mL)e

4 °C (storage)

Sievers et al. 2003a [52]

Hypotonic sterile water solution (treatment); multi-day washout period with isotonic neutral buffer solution (unspecified)

Ribonuclease + deoxyribonuclease

Antibiotic + antimycotic (unspecified)

 

Tavakkol et al. 2005a [53]

Hypotonic sterile water solution (treatment); multi-day washout period with isotonic neutral buffer solution (unspecified)

Ribonuclease + deoxyribonuclease

Antibiotic + antimycotic (unspecified)

 
  1. °C degrees celsius, Ltd. limited liability company, mL milliliter, NaCl sodium chloride, PBS phosphate-buffered saline
  2. aPulmonary homograft decellularized according to the SynerGraftâ„¢ treatment protocol (CryoLife Inc., Kennesaw, Georgia, US) [54]
  3. bDecellularization of pulmonary homograft performed at corlife oHG (corlife oHG, Hannover Medical School, Hannover, DE)
  4. cPulmonary homograft decellularized according to the patented process developed by AutoTissue Ltd. (AutoTissue GmbH, Berlin, DE) [27]
  5. dPulmonary homograft decellularized according to the patented process developed by Tissue Regenix Ltd. (Tissue Regenix Ltd., Leeds, Yorkshire, UK) [28]
  6. ePenicillin-streptomycin solution manufactured by Cedarlane Laboratories (PenStrep, Cedarlane Laboratories, Burlington, Ontario, CA)